Prothena Corporation plc (PRTA)


NasdaqGS - NasdaqGS Delayed Price. Currency in USD
62.54-1.06 (-1.67%)
At close: 4:00 PM EDT
People also watch:
PTLAOPHTPTCTALDRAGIO
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open62.82
Prev Close63.60
Bid58.27 x 1000
Ask63.50 x 500
Day's Range62.08 - 64.50
52wk Range28.20 - 76.42
1y Target EstN/A
Market Cap2.15B
P/E Ratio (ttm)-17.86
Beta3.00
Volume247,957
Avg Vol (3m)407,177
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • GlobeNewswire3 days ago

    Prothena to Host Update on PRX003 Phase 2 Development Strategy

    DUBLIN, Ireland, Sept. 22, 2016 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the discovery, development, and commercialization of novel ...

  • GlobeNewswire3 days ago

    Prothena to Host Update on PRX003 Phase 2 Development Strategy

    DUBLIN, Ireland, Sept. 22, 2016-- Prothena Corporation plc, a late-stage clinical biotechnology company focused on the discovery, development, and commercialization of novel protein immunotherapies, today ...

  • Capital Cube10 days ago

    ETF’s with exposure to Prothena Corp. Plc : September 16, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Prothena Corp. Plc Here are 5 ETF’s with the largest exposure to PRTA-US. Comparing the performance and risk of Prothena Corp. Plc with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)